• LAST PRICE
    20.0450
  • TODAY'S CHANGE (%)
    Trending Up0.0050 (0.0250%)
  • Bid / Lots
    20.0100/ 4
  • Ask / Lots
    20.0800/ 2
  • Open / Previous Close
    20.3600 / 20.0400
  • Day Range
    Low 19.5400
    High 20.6000
  • 52 Week Range
    Low 13.4800
    High 32.6000
  • Volume
    75,316
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 20.02
TimeVolumeZLAB
09:32 ET837520.55
09:34 ET80020.51
09:36 ET70020.21
09:38 ET70020.22
09:41 ET10020.16
09:48 ET70020.09
09:54 ET50020
09:56 ET140020.05
09:57 ET150020.06
09:59 ET50020
10:06 ET365020.01
10:10 ET29520.02
10:14 ET10020.02
10:15 ET164920.04
10:17 ET82520.035
10:24 ET20020
10:26 ET619920
10:28 ET230019.96
10:30 ET50019.965
10:32 ET60020.02
10:37 ET45020.06
10:42 ET22520.03
10:48 ET50019.99
10:50 ET30019.99
10:51 ET60019.98
10:53 ET10020.02
11:02 ET40020
11:08 ET20019.995
11:09 ET380020.04
11:11 ET20020.015
11:15 ET10020
11:18 ET90020
11:20 ET20019.99
11:22 ET132120
11:24 ET70020
11:26 ET50020.02
11:29 ET10020
11:31 ET20020
11:33 ET20020
11:36 ET10020
11:38 ET70020
11:40 ET90020.01
11:42 ET20020.04
11:45 ET30020.005
11:47 ET20020.025
11:49 ET30020.04
11:51 ET20020.05
11:54 ET558319.99
11:56 ET10020.025
11:58 ET254119.98
12:00 ET60020.01
12:02 ET30019.985
12:05 ET50020.045
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesZLAB
Zai Lab Ltd
1.9B
-5.7x
---
United StatesMRVI
Maravai LifeSciences Holdings Inc
2.1B
-8.0x
---
United StatesGLPG
Galapagos NV
1.7B
52.2x
---
United StatesDVAX
Dynavax Technologies Corp
1.6B
244.3x
---
United StatesADMA
ADMA Biologics Inc
2.4B
-528.7x
---
United StatesKNSA
Kiniksa Pharmaceuticals Ltd
1.4B
225.0x
---
As of 2024-06-12

Company Information

Zai Lab Ltd is a holding company mainly engaged in the biopharmaceutical field. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including oncology, autoimmune and infectious diseases fields. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include Niraparib (ZL-2306), ZL-2103, ZL-1101 and others.

Contact Information

Headquarters
4560 Jinke Road, Bldg. 1, 4/F, PudongSHANGHAI, SHA, China 201210
Phone
216-163-2588
Fax
216-163-2570

Executives

Chairman of the Board, Chief Executive Officer, Co-Founder
Du Ying
President, Chief Operating Officer
Joshua Smiley
Chief Financial Officer
Yajing Chen
President - Global Oncology Research and Development
Rafael Amado
President, Head - Global Development of Neuroscience, Autoimmune and Infectious Diseases
Harald Reinhart

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.9B
Revenue (TTM)
$291.1M
Shares Outstanding
99.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.06
EPS
$-3.50
Book Value
$8.19
P/E Ratio
-5.7x
Price/Sales (TTM)
6.6
Price/Cash Flow (TTM)
---
Operating Margin
-126.21%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.